Topical Methoxsalen and Blacklight in the Treatment of Psoriasis

Archives of Dermatology

Volumn 113, Issue 3, 1977, Pages 292-296

  Petrozzi, John W ^a   Kaidbey, Kays M ^a   Kligman, Albert M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE DERIVATIVE; METHOXSALEN; SALICYLIC ACID;

CLINICAL STUDY; DRUG THERAPY; MAJOR CLINICAL STUDY; PSORIASIS; THERAPY; TOPICAL DRUG ADMINISTRATION; ULTRAVIOLET RADIATION;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; BLISTER; CHILD; FEMALE; HUMAN; MALE; METHOXSALEN; MIDDLE AGE; PRURITUS; PSORIASIS; SKIN PIGMENTATION; ULTRAVIOLET THERAPY;

EID: 0017324241     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1977.01640030038004     Document Type: Article

References (19)

1. 1. Alderson JE: Heliotherapy in psoriasis. Arch Dermatol Syphilol 8:79-80, 1923.
2. 2. Goeckerman WH: The treatment of psoriasis. Northwest Med 24:229-231, 1925.
3. 3. Goeckerman WH: Treatment of psoriasis. Arch Dermatol Syphilol 24:446-450, 1923.
4. 4. Perry HO, Soderstrom CW, Schulze RW: The Goeckerman treatment of psoriasis. Arch Dermatol 98:178-182, 1968.
5. 5. Everett MA, Miller JV: Coal tar and ultraviolet light: II. Cummulative effects. Arch Dermatol 84:937-940, 1961.
6. 6. Epstein JH, Fukuyama K: Effects of 8-methoxypsoralen (8-MOP) induced phototoxic effects on mammalian epidermal macromolecular synthesis in vivo. Photochem Photobiol 21:325-330, 1975.
7. 7. Baden HP, Parrington JM, Delhandty JDA, et al: DNA synthesis in normal and xeroderma pigmentosum fibroblasts following treatment with 8-methoxypsoralen and long wave ultraviolet light. Biochem Biophys Acta 261:247-248, 1972.
8. 8. Walter JE, Voorhees JJ, Kelsey WH, et al: Psoralen plus blacklight inhibits epidermal DNA synthesis. Arch Dermatol 107:861-865, 1973.
9. 9. Allyn B: Studies on phototoxicity in man and laboratory animals. Read before the 21st. annual meeting of the American Academy of Dermatology, Chicago, December 1962.
10. 10. Willis I, Harris DR: Resistant psoriasis: Combined methoxsalen-anthralin therapy. Arch Dermatol 107:358-362, 1973.
11. 11. Walter JF, Voorhees JJ: Psoriasis improved by psoralens plus blacklight. Acta Derm Venereol (Stockh) 53:469-472, 1973.
12. 12. Kligman A, Goldstein FP: Oral dosage in methoxsalen phototoxicity. Arch Dermatol 107:548-550, 1973.
13. 13. Pathak MA, Fellman JH, Kaufman KD: The effect of structural alterations on the erythemal activity of furocoumarins: Psoralens. J Invest Dermatol 35:165-183, 1960.
14. 14. Weber G: Combined 8-methoxypsoralen and blacklight therapy of psoriasis. Br J Dermatol 90:317-323, 1974.
15. 15. Tronnier H, Schule D: Zur dermatologischen therapie von dermatosen mit langwelligem UV nach photosensibilisierung der huat mit Methoxsalen erste ergebnisse bei der psoriasis vulgaris. Z Haut Geschlechtskr 48:385-393, 1973.
16. 16. Parrish JH, Fitzpatrick T, Tanenbaum L, et al: Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med 291:3-7, 1974.
17. 17. Urbach F: Modification of ultraviolet carcinogenesis by photoactive agents. J Invest Dermatol 32:373-378, 1959.
18. 18. Forbes PD, Urbach F: Experimental modification of photocarcinogenesis: III. Simulation of exposures to sunlight and fluorescent whitening agents. Food Cosmet Toxicol 13:343-345, 1975.
19. 19. Fischer T, Juhlin L: Photochemotherapy of psoriasis with trioxsalen baths and dysprosium lamps. Arch Dermatol, to be published.